GLP2-TZ

Tirzepatide Vial Research Peptide 
High-Purity GLP-1 Analog | USA-Based Shipping | For Research Use Only

Tirzepatide is a novel dual GIP/GLP-1 receptor agonist, currently under investigation for its potential role in metabolic and weight-related research applications. Its mechanism of action—simultaneously activating multiple incretin receptors—has made it a major focus of clinical study. While not approved for human consumption, Tirzepatide’s unique pharmacological profile has attracted global research interest.

Tirzepatide (Tirz) represents the next generation of metabolic research compounds. By acting as a dual agonist for both Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) receptors, it allows researchers to investigate synergistic pathways in glycemic management and lipid metabolism.

Key Features:

• ≥99% purity, third-party tested

• Ships fast from the USA

• Ideal for research institutions and laboratories

10~100mg/vial (single vial);    10 vials /kit.

Please Note: 10 vial kits are supplied without individual vial labels.